Currently, WS is life‐threatening and there is no effective therapy for WS patients who need exogenous insulin injection and die prematurely around 30 years old.[62] The bottleneck lies in poor understanding of the WS pathogenesis in human model. This evidence concerns the gene INS and Werner syndrome.